Location History:
- Ciudad de la Habana, CU (2014)
- Havana, CU (2018)
Company Filing History:
1 out of 15 
1 out of 70 
Years Active: 2014-2018
Title: Innovations in Antiviral Treatments by Mónica Sarría Núñez
Introduction
Mónica Sarría Núñez, an innovative inventor based in Havana, Cuba, has made significant contributions to the field of antiviral research. With two notable patents to his name, Núñez has focused on developing effective treatments against viral infections, particularly those caused by the Dengue virus and members of the Flaviviridae family.
Latest Patents
His latest patents include groundbreaking work on beta hairpin peptides that exhibit antiviral properties against the Dengue virus. This invention presents structurally constrained synthetic peptides optimized for the formation of a beta hairpin structure. These peptides have demonstrated the ability to inhibit or attenuate Dengue virus (DENV) infections. Furthermore, the invention encompasses pharmaceutical compositions that utilize these synthetic peptides, aimed at preventing and treating infections caused by DENV.
Núñez's other significant patent involves the development of chimerical peptidic molecules displaying antiviral properties against viruses from the Flaviviridae family. This invention consists of chimerical peptides with a primary structure that includes segments inhibiting the activation of the NS3 protease of the virus. These peptides also contain a cell-penetrating segment that makes them capable of inhibiting or reducing viral infections. The patent extends to pharmaceutical compounds containing these chimerical peptides designed for the prevention and treatment of infections caused by Flaviviridae viruses.
Career Highlights
Throughout his career, Mónica Sarría Núñez has worked with prominent organizations such as the Centro de Ingeniería Genética y Biotecnología, where he honed his skills in genetic engineering and biotechnology, contributing to cutting-edge research in the field. His dedication to advancing science has led to outstanding innovations that hold the potential for transforming antiviral treatment strategies.
Collaborations
Núñez has collaborated with esteemed coworkers, including Glay Chinea Santiago and Vivian Huerta Galindo. These partnerships have fostered a collaborative environment where ideas flourish, leading to further advancements in antiviral therapies and fostering a spirit of innovation within the biotechnology community.
Conclusion
Mónica Sarría Núñez stands at the forefront of antiviral research with his innovative patents and collaborations. His work not only addresses critical health challenges but also contributes to a deeper understanding of viral mechanisms, showcasing the importance of innovation in developing effective medical treatments. Through his contributions, he inspires future generations of inventors and researchers in the fight against viral infections.